o chargeupon request to Georgeson Inc. the information agent for th...(Logo: A HREF http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO ...
Date:10/14/2008
o charge
upon request to Georgeson, Inc., the information agent for the tender offer
at (800) 262-1918 (toll free). In addition, all of those materials (and all
other offer documents filed with the SEC) are available at no charge on the
SEC's website at
http://www.sec.gov .
(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )
'/>"/>SOURCE Eli Lilly and Company Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation2.
Lilly Declares Fourth-Quarter Dividend3.
Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar4.
Lilly and BioMS Medical Announce Global Licensing and Development Agreement5.
Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration6.
In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:7.
Lilly Announces Termination of AIR Insulin Program8.
HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership9.
Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education10.
Lilly Reports Solid First-Quarter Results11.
Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs